Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization

Journal of the American College of Cardiology

Volumn 61, Issue 15, 2013, Pages 1616-1623

  Aldweib, Nael ^a   Negishi, Kazuaki ^a   Hachamovitch, Rory ^a   Jaber, Wael A ^a   Seicean, Sinziana ^a   Marwick, Thomas H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

ischemia; outcome; revascularization; SPECT

Indexed keywords

AGE; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CAUSE OF DEATH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; PROPENSITY SCORE; SILENT MYOCARDIAL ISCHEMIA; SURVIVAL; TREATMENT OUTCOME;

AGE FACTORS; AGED; ASYMPTOMATIC DISEASES; CARDIOVASCULAR AGENTS; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; REOPERATION; RISK ASSESSMENT;

EID: 84876009562     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.043     Document Type: Article

References (32)

1. P.C. Deedwania, E.V. Carbajal Silent myocardial ischemia A clinical perspective Arch Intern Med 151 1991 2373 2382
2. A.C. Yeung, J. Barry, J. Orav, E. Bonassin, K.E. Raby, A.P. Selwyn Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease Circulation 83 1991 1598 1604
3. W. Palmas, S. Bingham, G.A. Diamond Incremental prognostic value of exercise thallium-201 myocardial single-photon emission computed tomography late after coronary artery bypass surgery J Am Coll Cardiol 25 1995 403 409
4. M.J. Zellweger, H.C. Lewin, S. Lai When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies J Am Coll Cardiol 37 2001 144 152
5. R.C. Hendel, D.S. Berman, M.F. Di Carli ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/ SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine J Am Coll Cardiol 53 2009 2201 2229
6. C.J. Pepine, P.F. Cohn, P.C. Deedwania Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life The Atenolol Silent Ischemia Study (ASIST) Circulation 90 1994 762 768
7. W.J. Rogers, M.G. Bourassa, T.C. Andrews Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization The ACIP Investigators J Am Coll Cardiol 26 1995 594 605
8. S.C. Harb, T. Cook, W.A. Jaber, T.H. Marwick Exercise testing in asymptomatic patients after revascularization: are outcomes altered? Arch Intern Med 172 2012 854 861
9. W.E. Boden, R.A. O'Rourke, K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
10. L.J. Shaw, W.S. Weintraub, D.J. Maron Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention Am Heart J 164 2012 243 250
11. R. Hachamovitch, S.W. Hayes, J.D. Friedman, I. Cohen, D.S. Berman Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2003 2900 2907
12. R. Hachamovitch, A. Rozanski, S.W. Hayes Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 13 2006 768 778
13. C.L. Hansen, R.A. Goldstein, D.S. Berman Myocardial perfusion and function single photon emission computed tomography J Nucl Cardiol 13 2006 e97 e120
14. M.D. Cerqueira, N.J. Weissman, V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
15. G. Germano, H. Kiat, P.B. Kavanagh Automatic quantification of ejection fraction from gated myocardial perfusion SPECT J Nucl Med 36 1995 2138 2147
16. M.L. Ladenheim, B.H. Pollock, A. Rozanski Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease J Am Coll Cardiol 7 1986 464 471
17. D.B. Rubin Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 1997 757 763
18. A. Sjolander Propensity scores and M-structures Stat Med 28 2009 1416 1420 author reply 1420-3
19. S. Greenland Modeling and variable selection in epidemiologic analysis Am J Public Health 79 1989 340 349
20. D.W. Hosmer, S. Lemeshow Applied Logistic Regression 2nd edition 2000 Wiley New York, NY
21. F. Harrell Predicting Outcomes: Applied Survival Analysis and Logistic Regression 2000 University of Virginia Charlottesville, VA
22. D. Cox Regression models and life tables J R Stat Soc Ser B Methodol 34 1972 187 220
23. G. Gosselin, K.K. Teo, J.F. Tanguay Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial) Am J Cardiol 109 2012 954 959
24. R. Hachamovitch, A. Rozanski, L.J. Shaw Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 32 2011 1012 1024
25. H.C. Bucher, P. Hengstler, C. Schindler, G.H. Guyatt Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials BMJ 321 2000 73 77
26. A.J. Solomon, B.J. Gersh Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery Lessons from the randomized trials Ann Intern Med 128 1998 216 223
27. S. Yusuf, D. Zucker, P. Peduzzi Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
28. P. Erne, A.W. Schoenenberger, D. Burckhardt Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial JAMA 297 2007 1985 1991
29. R.M. Califf, F.E. Harrell Jr., K.L. Lee The evolution of medical and surgical therapy for coronary artery disease A 15-year perspective JAMA 261 1989 2077 2086
30. R. Hachamovitch, L. Shaw, D.S. Berman Methodological considerations in the assessment of noninvasive testing using outcomes research: pitfalls and limitations Prog Cardiovasc Dis 43 2000 215 230
31. P.R. Rosenbaum, D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
32. P.W. Serruys, M.C. Morice, A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972